期刊
NATURE REVIEWS CANCER
卷 6, 期 9, 页码 688-701出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1958
关键词
-
类别
The transfer of polymer - protein conjugates into routine clinical use, and the clinical development of polymer-anticancer-drug conjugates, both as single agents and as components of combination therapy, is establishing polymer therapeutics as one of the first classes of anticancer nanomedicines. There is growing optimism that ever more sophisticated polymer-based vectors will be a significant addition to the armoury currently used for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据